Bots, editor, reviewer, Administrators
13,951
edits
WikiJournalClub:Usable articles: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 49: | Line 49: | ||
* [[BRIDGE]] (2015): LMWH bridging for surgery in AF | * [[BRIDGE]] (2015): LMWH bridging for surgery in AF | ||
* [[FIRE AND ICE]] (2016): Cryoablation vs. RF ablation in pAF | * [[FIRE AND ICE]] (2016): Cryoablation vs. RF ablation in pAF | ||
* [[ISAR-TRIPLE]] (2015): Triple therapy for 6 weeks vs. 6 months after DES placement | |||
* [[ORBIT-AF]] (2013): ASA/warfarin vs. warfarin in AF | * [[ORBIT-AF]] (2013): ASA/warfarin vs. warfarin in AF | ||
* [[RACE II]] (2010): Lenient vs. strict rate control in AF | * [[RACE II]] (2010): Lenient vs. strict rate control in AF | ||
| Line 94: | Line 95: | ||
* [[HOPE]] (2000): Ramipril in patients with high CV risk | * [[HOPE]] (2000): Ramipril in patients with high CV risk | ||
* [[HPS2-THRIVE]] (2014): Niacin in atherosclerotic disease | * [[HPS2-THRIVE]] (2014): Niacin in atherosclerotic disease | ||
* [[ISAR-TRIPLE]] (2015): Triple therapy for 6 weeks vs. 6 months after DES placement | |||
* [[JUPITER]] (2008): Rosuvastatin for primary CV prevention | * [[JUPITER]] (2008): Rosuvastatin for primary CV prevention | ||
* [[LoDoCo]] (2013): Colchicine for stable CAD | * [[LoDoCo]] (2013): Colchicine for stable CAD | ||